SUMMARY Reduced renal 15-hydroxyprostaglandin dehydrogenase (PGDH) activity has been proposed as a cause, subsequent to elevation of intrarenal prostaglandin (PG) E, levels, of the development or maintenance of high blood pressure (BP) in the New Zealand genetically hypertensive (NZGH) rat. To test this hypothesis, PGDH activity in homogenates of kidneys and lungs and in urine concentration and excretion of PGE, were determined in male and female NZGH and normotensive control (NZNR) rats. Lung PGDH activities of the four groups were similar. Renal PGDH activity was 50% lower for the male NZGH than for the male NZNR, but for the female rats no difference in renal PGDH activity was found between NZGH and NZNR. In addition, there was a large sex-related difference in renal PGDH activities, values for the female rats being only 5% to 10% of the values for males. Urine PGE, concentration and excretion were two to five times greater for the female rats than for the males, but did not differ between male NZGH and male NZNR. From these observations, it appears that neither renal PGDH activity nor urine PGE, levels is associated with hypertension in the New Zealand genetically hypertensive strain of rats. 1 Although the causal mechanism underlying the development of high blood pressure (BP) in this strain remains undefined, it has been proposed that altered prostaglandin (PG) metabolism in the kidney may be a contributing factor. The basis for this proposal rests on several observations. Armstrong et al. 3 found that the activity of 15-hydroxyprostaglandin dehydrogenase (PGDH) in kidneys from male NZGH is only about 30% of that in kidneys from male NZNR, but that renal prostaglandin (PG) synthetase activities were not different. PGDH is a major prostaglandincatabolizing enzyme in rat kidney, oxidizing PGEj and PGF,a to 15-keto metabolites,' and its activity could be a determinant of intrarenal levels of these 1 From these observations, it was proposed that increased PGE, levels in the kidney, resulting from lower PGDH activity, might contribute to the development or maintenance of hypertension in the NZGH, through direct or indirect renal vasoconstrictor effects of PGE,.
2We recently observed, in normal Wistar rats, that PGDH activity is approximately 40 times greater in the kidneys of males than in the kidneys of females; 7 this difference between male and female normotensive rats is far greater than the differences reported 1 ' *~1 0 between genetically hypertensive and normotensive male rats. In the present study, we have compared renal prostaglandin metabolizing activity, and urinary prostaglandin excretion, in male and female rats of the New Zealand genetically normotensive and hypertensive strains. In addition to confirming that PGDH activity is lower in the kidneys of male NZGH than in the kidneys of male NZNR, we found that renal PGDH activity of female NZGH and NZNR is much lower than that of the males of the two strains. In addition, we found no difference between the PGDH activities of female NZGH and female N...